Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...
People who take this pill don't have to adhere to rules like taking it first thing in the morning or on an empty stomach.
As patents on semaglutide expire, manufacturers are poised to introduce cheaper generic versions of blockbuster drugs, with far-reaching effects on the obesity crisis. Megan Tatum reports.
When kids with ADHD need medicines to help with symptoms like hyperactivity, inattention, or impulsivity, doctors usually suggest stimulants first. But some children don’t respond well to these drugs ...
HealthDay News — Glucagon-like peptide-1 (GLP-1) receptor agonists, especially semaglutide, are associated with a reduced risk for worsening of anxiety and depression that co-occur with diabetes and ...
The FDA has approved Orforglipron as the second oral GLP-1 receptor agonist for weight management in adults with obesity or ...
According to the in-depth study published by MarkNtel Advisors, the Global GLP-1 Receptor Agonist Market is projected to grow at a CAGR of around 3.66% during 2026–2032. The market expansion is ...
The Annals of Pharmacotherapy. 2012;46(5):710-717. There are several limitations to the available data. First, single-dose drug interaction studies do not permit examination of the effects of repeat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results